The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11147 malaria professionals are enjoying the free benefits of MalariaWorld today

eradication

Open Access | Dry Season Determinants of Malaria Disease and Net Use in Benin, West Africa

February 8, 2012 - 14:59 -- Kabogo Ndegwa
Author(s): 
Nicolas Moiroux, Olayidé Boussari, Armel Djènontin, Georgia Damien, Gilles Cottrell, Marie-Claire Henry, Hélène Guis, Vincent Corbel
Reference: 
PLoS ONE 7(1): e30558

MalariaWorldAs recommended by the Malaria Eradication (MalERA) Consultative Group on Modelling, there is a need to understand better the effects of seasonality on malaria morbidity.

Medical Condition: 

Open Access | A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication

January 27, 2011 - 10:09 -- Kabogo Ndegwa
Author(s): 
The malERA Consultative Group on Integration Strategies
Reference: 
PLoS Med 8(1): e1000404

Discipline-specific Malaria Eradication Research Agenda (malERA) Consultative Groups have recognized several cross-cutting issues that must be addressed to prevent repetition of some of the mistakes of past malaria elimination campaigns in future programs.

Organization: 
Medical Condition: 
Medical Treatment: 

Open Access | Some Lessons for the Future from the Global Malaria Eradication Programme (1955–1969)

January 27, 2011 - 10:05 -- Kabogo Ndegwa
Author(s): 
José A. Nájera, Matiana González-Silva, Pedro L. Alonso
Reference: 
PLoS Med 8(1): e1000412

Encouraged by the early success of using dichloro-diphenyl-trichloroethane (DDT) against malaria, the World Health Organization (WHO) embarked on the Global Malaria Eradication Program (GMEP) in 1955.

Organization: 
Medical Condition: 
Medical Treatment: 

Open Access | A Research Agenda for Malaria Eradication: Modeling

January 27, 2011 - 10:03 -- Kabogo Ndegwa
Author(s): 
The malERA Consultative Group on Modeling
Reference: 
PLoS Med 8(1): e1000403

Malaria modeling can inform policy and guide research for malaria elimination and eradication from local implementation to global policy.

Organization: 
Medical Condition: 
Medical Treatment: 

Open Access | A Research Agenda for Malaria Eradication: Health Systems and Operational Research

January 27, 2011 - 09:59 -- Kabogo Ndegwa
Author(s): 
The malERA Consultative Group on Health Systems and Operational Research
Reference: 
PLoS Med 8(1): e1000397

Health systems research and development is needed to support the global malaria eradication agenda.

Company: 
Medical Condition: 
Medical Treatment: 

Open Access | A Research Agenda for Malaria Eradication: Diagnoses and Diagnostics

January 27, 2011 - 09:57 -- Kabogo Ndegwa
Author(s): 
The malERA Consultative Group on Diagnoses and Diagnostics
Reference: 
PLoS Med 8(1): e1000396

Many of malaria's signs and symptoms are indistinguishable from those of other febrile diseases.

Organization: 
Medical Condition: 
Medical Treatment: 

Open Access | A Research Agenda for Malaria Eradication: Vector Control

January 27, 2011 - 09:54 -- Kabogo Ndegwa
Author(s): 
The malERA Consultative Group on Vector Control
Reference: 
PLoS Med 8(1): e1000401

Different challenges are presented by the variety of malaria transmission environments present in the world today.

Organization: 
Medical Condition: 
Medical Treatment: 

Open Access | A Research Agenda to Underpin Malaria Eradication

January 27, 2011 - 09:44 -- Kabogo Ndegwa
Author(s): 
Pedro L. Alonso, Graham Brown, , Marcel Tanner, et al.
Reference: 
PLoS Med 8(1): e1000406

The interruption of malaria transmission worldwide is one of the greatest challenges for international health and development communities.

Organization: 
Medical Condition: 
Medical Treatment: 

Open Access | Invited Speaker Presentation: New medicines to improve control and contribute to the eradication of malaria

November 3, 2010 - 14:54 -- Patrick Sampao
Author(s): 
Timothy NC Wells
Reference: 
Malaria Journal 2010, 9(Suppl 2):I15 (20 October 2010)

Despite being one of the most prevalent tropical diseases, for many years malaria was not a commercial priority for the pharmaceutical industry.

Medical Condition: 
Medical Treatment: 

Pages

Subscribe to RSS - eradication